MINELLI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 7.748
AS - Asia 3.747
EU - Europa 3.020
SA - Sud America 851
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 110
OC - Oceania 20
AN - Antartide 1
Totale 15.731
Nazione #
US - Stati Uniti d'America 7.403
SG - Singapore 1.183
CN - Cina 1.174
BR - Brasile 710
IT - Italia 692
PL - Polonia 483
UA - Ucraina 421
HK - Hong Kong 412
DE - Germania 336
VN - Vietnam 307
FR - Francia 230
BD - Bangladesh 223
FI - Finlandia 213
GB - Regno Unito 202
CA - Canada 161
TR - Turchia 116
RU - Federazione Russa 111
IN - India 99
IE - Irlanda 95
MX - Messico 58
AR - Argentina 48
ZA - Sudafrica 36
ID - Indonesia 33
IQ - Iraq 32
NL - Olanda 32
AT - Austria 28
EC - Ecuador 28
LT - Lituania 27
SE - Svezia 26
ES - Italia 25
PK - Pakistan 25
CZ - Repubblica Ceca 21
VE - Venezuela 21
CR - Costa Rica 20
JP - Giappone 20
SA - Arabia Saudita 20
MA - Marocco 18
TT - Trinidad e Tobago 18
AU - Australia 17
CO - Colombia 17
IL - Israele 17
BE - Belgio 16
HN - Honduras 16
JM - Giamaica 14
GT - Guatemala 12
CL - Cile 11
KE - Kenya 11
NO - Norvegia 11
SV - El Salvador 10
PR - Porto Rico 9
AE - Emirati Arabi Uniti 8
CW - ???statistics.table.value.countryCode.CW??? 8
EG - Egitto 8
JO - Giordania 8
KZ - Kazakistan 8
NG - Nigeria 8
SC - Seychelles 8
BG - Bulgaria 7
DZ - Algeria 7
EE - Estonia 7
NI - Nicaragua 7
UZ - Uzbekistan 7
MY - Malesia 6
PE - Perù 6
AL - Albania 5
BB - Barbados 5
HU - Ungheria 5
KR - Corea 5
LV - Lettonia 5
PH - Filippine 5
PY - Paraguay 5
AM - Armenia 4
CH - Svizzera 4
EU - Europa 4
KG - Kirghizistan 4
OM - Oman 4
TN - Tunisia 4
BS - Bahamas 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GP - Guadalupe 3
IR - Iran 3
LK - Sri Lanka 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
Totale 15.486
Città #
Ashburn 765
Singapore 623
Fairfield 617
Woodbridge 529
Warsaw 476
Hong Kong 409
San Jose 403
Jacksonville 301
Council Bluffs 293
Houston 283
Ann Arbor 265
Seattle 255
Cambridge 231
The Dalles 222
Beijing 220
New York 209
Wilmington 194
Princeton 170
Chandler 150
Los Angeles 150
Helsinki 115
Lauterbourg 115
Brescia 112
Dearborn 112
Ho Chi Minh City 103
Nanjing 100
Istanbul 92
Dublin 90
Munich 87
Milan 81
São Paulo 81
Santa Clara 77
Columbus 72
Buffalo 68
Chicago 64
San Francisco 60
Dallas 57
Des Moines 53
Hanoi 53
Toronto 53
North Bergen 51
Turku 47
Shanghai 46
Nanchang 45
Redondo Beach 45
Jinan 44
Shenyang 44
Boardman 41
Bolzano 40
Hebei 39
Moscow 39
Verona 39
Changsha 37
Orem 36
Dong Ket 34
Denver 33
San Diego 32
Brooklyn 30
Rome 30
Atlanta 29
Phoenix 29
London 28
Frankfurt am Main 26
Lancaster 26
Tianjin 26
Mexico City 24
Montreal 24
Nuremberg 24
Johannesburg 22
Guangzhou 20
Belo Horizonte 19
Naples 19
Rio de Janeiro 19
Zhengzhou 19
San José 18
Ningbo 17
Salt Lake City 17
Tokyo 17
Brasília 16
Brussels 16
Haiphong 16
Brno 15
Hangzhou 15
Norwalk 15
Stockholm 15
Da Nang 13
Jakarta 13
Jiaxing 13
Sorocaba 13
Chennai 12
Curitiba 12
Haikou 12
Lanzhou 12
Turin 12
Düsseldorf 11
Guayaquil 11
Hefei 11
Manchester 11
Poplar 11
Quito 11
Totale 9.871
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 336
New Copy Number Variations in Schizophrenia 333
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 278
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 244
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 220
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder 219
Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium 214
Clinical efficacy of trauma-focused psychotherapies in treatment-resistant depression (TRD) in-patients: A randomized, controlled pilot-study 209
Childhood neglect, the neglected trauma. A systematic review and meta-analysis of its prevalence in psychiatric disorders 203
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 202
The role of the potassium channel gene KCNK2 in major depressive disorder 202
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 195
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 190
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 184
The role of GRIK4 gene in treatment-resistant depression 184
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 182
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 176
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 175
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 170
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 166
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 165
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 165
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 163
PCLO gene: Its role in vulnerability to major depressive disorder. 161
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 161
On the neural control of social emotional behavior 159
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 158
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 157
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 156
Erbb3 leukocytes mRNA levels as biomarker of Major Depression. 155
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 155
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients 153
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 153
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 150
Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review 148
New Copy Number Variations in Schizophrenia Italian Patients 147
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 147
5-Httlpr/Rs25531 And Fkbp5 Polymorphisms Epistasis In Treatment-Resistant Depressed Patients 146
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 144
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 144
Biological correlates of early life stressful events in major depressive disorder 144
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 142
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 142
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. 140
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor 140
Serotonin transporter gene polymorphisms and treatment-resistant depression. 136
Lateralized readiness potential elicited by undetected visual stimuli 135
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic) 135
Psychological impact of Covid-19 pandemic in mental healthcare workers: a cross-sectional study in an Italian Department of Mental Health 133
Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients 133
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 133
Costituenti cognitive di invidia, vergogna e senso di colpa associate alla gravità della psicopatologia 132
Long-lasting effects of high frequency repetitive transcranial magnetic stimulation in major depressed patients 132
[Effectiveness of cognitive-associated with behavioral therapy psychopharmacological depression. Literature review meta-analyses] 131
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response 131
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers 131
Analysis of Citalopram response heterogeneity among STAR*D patients using in-silico methods 129
Childhood trauma and glucose metabolism in patients with first-episode psychosis 127
Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders 127
Blood transcriptomic analysis reveals a distinct molecular subtype of treatment resistant depression compared to non-treatment resistant depression 127
Is blindsight in normals akin to blindsight following brain damage? 126
Treatments of trauma: A review of actions and techniques 124
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 121
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 120
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 117
P.0106 Pharmacogenetic gene variants in treatment-resistant depression: preliminary results of a pilot study 116
Blues in the brain and beyond: Molecular bases of major depressive disorder and relative pharmacological and non-pharmacological treatments 115
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 114
Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in depressed patients. 114
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 113
Biological markers of sex-based differences in major depressive disorder and in antidepressant response 111
Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment 109
Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression 109
Molecular biomarkers of electroconvulsive therapy effects and clinical response: Understanding the present to shape the future 108
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 105
Assessment of haptoglobin alleles in autism spectrum disorders 104
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 101
Transcriptional Modulation of Stress-Related Genes in Association with Early Life Stress Exposure and Trauma-Focused Psychotherapy in Treatment-Resistant Depression Patients 101
The role of MED22 and its transcriptional interactions with childhood trauma and trauma-focused psychotherapy in patients with major depressive disorder 100
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 98
Leukocyte Telomere Length and Mitochondrial DNA Copy Number in Treatment-Resistant Depression and Response to Electroconvulsive Therapy: A Pilot Longitudinal Study 97
Genetics of anxiety disorders. 97
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 96
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 96
DNA methylation changes in association with trauma-focused psychotherapy efficacy in treatment-resistant depression patients: a prospective longitudinal study 95
Personality traits in an Italian sample: Relationship with anxiety and depression 94
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 94
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 93
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 93
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 91
Vascular Endothelial Growth Factor (VEGF) serum concentration: putative predictive biomarker for Electroconvulsive Therapy in depressed patients. 90
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 90
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 88
Everything changes but nothing changes: gender stereotypes in the Italian population 87
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort 85
No Less No More: The number of electroconvulsive therapy (ECT) trials for symptomatology improvement. 85
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder 84
Fibroblasts Transcriptional Profiles In Schizophrenia 83
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 80
ELECTROPHYSIOLOGICAL EVIDENCE OF MOTOR PREPARATION IN RESPONSE TO UNDETECTED VISUAL STIMULI. 80
Totale 14.073
Categoria #
all - tutte 71.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022568 0 0 0 0 11 40 78 46 90 74 48 181
2022/2023566 104 5 16 35 31 158 4 61 84 10 40 18
2023/2024807 45 19 77 71 37 140 24 21 169 19 35 150
2024/20252.114 32 27 28 253 142 178 179 84 198 303 370 320
2025/20264.798 415 597 312 623 520 297 648 192 301 396 280 217
2026/20271.895 201 314 410 917 53 0 0 0 0 0 0 0
Totale 15.731